Home › NDC Lookup › RxCUI directory › RxCUI 2058949

0.5 ML omalizumab 150 MG/ML Prefilled Syringe — RxCUI 2058949

Name: 0.5 ML omalizumab 150 MG/ML Prefilled Syringe (RxCUI 2058949)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 2058949 Semantic clinical drug · SCD ● Current RxNorm concept 4 FDA products 18 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2058949

Official name0.5 ML omalizumab 150 MG/ML Prefilled Syringe

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known asomalizumab 75 MG per 0.5 ML Prefilled Syringe; omalizumab 75 MG in 0.5 ML Prefilled Syringe

FDA products mapped4

Package NDCs mapped18

Reported Medicaid activity (SDUD)153,398 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Omalizumab Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Xolair targets IgE, the antibody your immune system overproduces in response to allergens. It blocks IgE from latching onto immune cells that would otherwise trigger your allergic...
What exactly is Xolair doing in my body, and why does it take so long to work?
It's worth knowing about, but your care team will take precautions. Xolair can cause anaphylaxis — a severe allergic reaction — in a small number of patients, and it can happen aft...
I've heard Xolair can cause a serious allergic reaction. Should I be worried?

📖 Read our full Omalizumab Injection guide →

🕸️ Concept Web — How 0.5 ML omalizumab 150 MG/ML Prefilled Syringe Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept 0.5 ML omalizumab 150 MG/ML Prefilled Syringe RxCUI 2058949 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Omalizumab 302379 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Xolair 356767 BN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Omalizumab Prefilled Syringe 2058942 SCDF
- Omalizumab Injectable Product 1159566 SCDG
- Omalizumab Prefilled Syringe [Xolair] 2058945 SBDF
- Xolair Injectable Product 1186440 SBDG
- Prefilled Syringe 721656 DF
- Injectable Product 1151126 DFG
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Omalizumab 150 MG/ML 2058941 SCDC
- 0.5 ML omalizumab 150 MG/ML Prefilled Syringe [Xolair] 2058950 SBD
- Omalizumab 150 MG/ML [Xolair] 2058944 SBDC

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Omalizumab 150 MG/ML SCDC · 2058941
Omalizumab Prefilled Syringe SCDF · 2058942
Omalizumab Injectable Product SCDG · 1159566

Brand-Name Concepts

0.5 ML omalizumab 150 MG/ML Prefilled Syringe [Xolair] SBD · 2058950
Omalizumab 150 MG/ML [Xolair] SBDC · 2058944
Omalizumab Prefilled Syringe [Xolair] SBDF · 2058945
Xolair Injectable Product SBDG · 1186440
Xolair BN · 356767

📦 FDA Products & Package NDCs

4 products · 18 package NDCs

18 package NDCs map to RxCUI 2058949 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
50242-0040-62	1 VIAL, SINGLE-USE in 1 CARTON (50242-040-62) / 1.2 mL in 1...	XOLAIR	Genentech, Inc.	2003-06-20
50242-0040-86	1 VIAL, SINGLE-USE in 1 CARTON (50242-040-86) / 1.2 mL in 1...	XOLAIR	Genentech, Inc.	2013-12-20
50242-0214-01	1 SYRINGE, GLASS in 1 CARTON (50242-214-01) / .5 mL in 1 SY...	Xolair PFS	Genentech, Inc.	2018-09-28
50242-0214-03	1 SYRINGE, GLASS in 1 CARTON (50242-214-03) / .5 mL in 1 SY...	Xolair PFS	Genentech, Inc.	2023-08-18
50242-0214-55	1 SYRINGE, GLASS in 1 CARTON (50242-214-55) / .5 mL in 1 SY...	Xolair PFS	Genentech, Inc.	2023-08-18
50242-0214-83	1 SYRINGE, GLASS in 1 CARTON (50242-214-83) / .5 mL in 1 SY...	Xolair PFS	Genentech, Inc.	2023-08-18
50242-0214-86	1 SYRINGE, GLASS in 1 CARTON (50242-214-86) / .5 mL in 1 SY...	Xolair PFS	Genentech, Inc.	2018-09-28
50242-0214-99	1 SYRINGE, GLASS in 1 CARTON (50242-214-99) / .5 mL in 1 SY...	Xolair PFS	Genentech, Inc.	2023-08-18
50242-0215-01	1 SYRINGE, GLASS in 1 CARTON (50242-215-01) / 1 mL in 1 SYR...	Xolair PFS	Genentech, Inc.	2018-09-28
50242-0215-03	1 SYRINGE, GLASS in 1 CARTON (50242-215-03) / 1 mL in 1 SYR...	Xolair PFS	Genentech, Inc.	2023-08-18
50242-0215-55	1 SYRINGE, GLASS in 1 CARTON (50242-215-55) / 1 mL in 1 SYR...	Xolair PFS	Genentech, Inc.	2023-08-18
50242-0215-83	1 SYRINGE, GLASS in 1 CARTON (50242-215-83) / 1 mL in 1 SYR...	Xolair PFS	Genentech, Inc.	2023-08-18
50242-0215-86	1 SYRINGE, GLASS in 1 CARTON (50242-215-86) / 1 mL in 1 SYR...	Xolair PFS	Genentech, Inc.	2018-09-28
50242-0215-99	1 SYRINGE, GLASS in 1 CARTON (50242-215-99) / 1 mL in 1 SYR...	Xolair PFS	Genentech, Inc.	2023-08-18
50242-0227-01	1 SYRINGE, GLASS in 1 CARTON (50242-227-01) / 2 mL in 1 SYR...	Xolair	Genentech, Inc.	2023-08-18
50242-0227-55	1 SYRINGE, GLASS in 1 CARTON (50242-227-55) / 2 mL in 1 SYR...	Xolair	Genentech, Inc.	2023-08-18
50242-0227-86	1 SYRINGE, GLASS in 1 CARTON (50242-227-86) / 2 mL in 1 SYR...	Xolair	Genentech, Inc.	2023-08-18
50242-0227-99	1 SYRINGE, GLASS in 1 CARTON (50242-227-99) / 2 mL in 1 SYR...	Xolair	Genentech, Inc.	2023-08-18

Observed labelers: Genentech, Inc. (18) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J2357	Omalizumab injection	9	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.